U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07379203) titled 'ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse' on Jan. 22.
Brief Summary: The goal of this clinical trial is to learn if valganciclovir works to treat cytomegalovirus (CMV) infection in people with advanced HIV disease. It will also look at the safety of valganciclovir and how the body handles the drug.
The main questions this study aims to answer are:
Does valganciclovir safely lower the amount of CMV virus in the blood of people with advanced HIV disease?
What medical problems or side effects do participants have when taking valganciclovir?
Researchers will compare valganciclovir to a placebo (a look-alike tablet tha...